Visualitza VHIO - Articles científics per autor "Elez Fernandez, Mª Elena"
Ara mostrant els elements 21-30 d 30
-
Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer
Fernández Montes, Ana; Elez Fernandez, Mª Elena; Vivancos Prellezo, Ana; Martínez, N.; González, P.; Covela, M. (Springer, 2022-06) -
Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors
Corti, Francesca; Infante, Gabriele; Elez Fernandez, Mª Elena; Ros Montañá, Fco. Javier; Fakih, Marwan; Pietrantonio, Filippo; Lonardi, Sara (BMJ, 2021-08) -
Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer
Kim, Tae Won; Yong, Wei Peng; Shiu, Kai-Keen; Vittrup, Benny; Elez Fernandez, Mª Elena; Yoshino, Takayuki; André, Thierry (Wiley, 2023-03) -
Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials
Matos Garcia, Ignacio; Hierro Carbó, Cinta; Martín Liberal, Juan Jesús; Berche, Roger; Pedrola Gómez, Anna; Braña Garcia, Irene; Azaro Pedrazzoli, Analía Beatriz; Vieito Villar, Maria; Saavedra Gadea, Omar; Gardeazabal, Itziar; Hernando Calvo, Alberto; Alonso-Casal, Guzman; Galvao De Aquiar, Vladimir; Ochoa de Olza Amat, Maria; Ros Montañá, Fco. Javier; Viaplana Donato, Cristina; Elez Fernandez, Mª Elena; Rodon Ahnert, Jordi; Macarulla Mercadé, Teresa; Oaknin Benzaquen, Ana Mazaltob; Carles Galceran, Joan; Felip Font, Enriqueta; Tabernero Caturla, Josep; Garralda Cabanas, Elena; Villacampa Javierre, Guillermo; Saura Manich, Cristina; Muñoz Couselo, Eva; Dienstmann, Rodrigo (Elsevier, 2021-09) -
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164
Le, Dung T.; Kim, Tae Won; Van Cutsem, Eric; Geva, Ravit; Jäger, Dirk; Hara, Hiroki; Elez Fernandez, Mª Elena (American Society of Clinical Oncology, 2020-01-01) -
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer
Elez Fernandez, Mª Elena; Ros Montañá, Fco. Javier; Fernández, Jose; Moreno-Cárdenas, Ana Belén; Arenillas Lallana, Carlota; Bernatowicz, Kinga; Fasani, Roberta; Garcia Rodriguez, Ariadna; Gonzalo-Ruiz, Javier; Piris-Giménez, Alejandro; Nuciforo, Paolo Giovanni; Vivancos Prellezo, Ana; Pérez López, Raquel; Tabernero Caturla, Josep; De Almeida Toledo, Rodrigo; Villacampa Javierre, Guillermo; Comas Navarro, Raquel; Dienstmann, Rodrigo (Nature Portfolio, 2022-10) -
Sex and gender perspectives in colorectal cancer
Baraibar Argota, Iosune; Ros Montañá, Fco. Javier; Salva Ballabrera, Francesc; Garcia Rodriguez, Ariadna; Rodriguez Castells, Marta; Tabernero Caturla, Josep; Elez Fernandez, Mª Elena; Saoudi Gonzalez, Nadia (Elsevier, 2023-04) -
Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer
Garazi, Serna; Cecchi, Fabiola; Fasani, Roberta; Thyparambil, Sheeno; Elez Fernandez, Mª Elena; Vivancos Prellezo, Ana; Tabernero Caturla, Josep; Nuciforo, Paolo Giovanni; Landolfi, Stefania; Ruiz Pace, Fiorella; Jimenez, Jose; Dienstmann, Rodrigo (Nature Publishing Group, 2019-09-19) -
The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series
Murali, Krithika; Thorne, Eleanor; Punie, Kevin; Kamposioras, Konstantnos; Oing, Christoph; Elez Fernandez, Mª Elena; Lim, Kok Haw Jonathan (Elsevier, 2022-02) -
The Medical Oncology resident mentor: situation and workload
Elez Fernandez, Mª Elena; Quintanar, T.; Bosch-Barrera, J; Corral, J.; Lainez, N.; Moreno, Victor (Springer, 2019-03-08)